Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

29 resultsUpdated October 25, 2026
1

Epidemiology of hepatitis C virus in Iran

World Journal of Gastroenterology 21(38) (2015)

Reza Taherkhani

2

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline

Hepatitis Monthly 16(8) (2016)

Seyed Moayed Alavian; Behzad Hajarizadeh; Kamran Bagheri Lankarani; Heidar Sharafi; Nasser Ebrahimi Daryani; Shahin Merat; Minoo Mohraz; Masoud Mardani; Mohammad Reza Fattahi; Hossein Poustchi; Mehri Nikbin; Mahmood Nabavi; Peyman Adibi; Masood Ziaee; Bita Behnava; Mohammad Saeid Rezaee Zavareh; Massimo Giuseppe Colombo; Hatef Massoumi; Abdul Rahman Bizri; Bijan Eghtesad; Majid Valiollahpour Amiri; Ali Namvar; Khashayar Hesamizadeh; Reza Malekzadeh

3

Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis

Hepatitis Monthly 16(4) (2016)

Farzin Sadeghi; ‪Mostafa Salehi-Vaziri; Amir Almasi‐Hashiani; Mohammad Gholami Fesharaki; Reza Pakzad; Seyed Moayed Alavian

4

Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C

Journal of Medical Virology 86(9) (2014)

Farzin Sadeghi; Farah Bokharaei‐Salim; ‪Mostafa Salehi-Vaziri; Seyed Hamidreza Monavari; Seyed Moayed Alavian; Shima Salimi; Rouhollah Vahabpour; Hossein Keyvani

5

Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients

World Journal of Gastroenterology 21(29) (2015)

Arghavan Haj-Sheykholeslami

6

High Resolution Melting Curve Assay for Detecting rs12979860 IL28B Polymorphisms Involved in Response of Iranian Patients to Chronic Hepatitis C Treatment

Asian Pacific Journal of Cancer Prevention 16(5) (2015)

Abolfazl Fateh; Mohammad Reza Aghasadeghi; Hossein Keyvani; Hamid Reza Mollaie; Shamsi Yari; Ali Reza Hadizade Tasbiti; Morteza Ghazanfari; Seyed Hamidreza Monavari

7

IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C

Archives of Virology 162(1) (2016)

Parvaneh Sedighimehr; Shiva Irani; Fatemeh Sakhaee; Farzam Vaziri; Mohammad Reza Aghasadeghi; Seyed Mehdi Sadat; Fatemeh Rahimi Jamnani; Abolfazl Fateh; Seyed Davar Siadat

8

Psychiatric side effects of pegylated interferon‑α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta‑analysis

Experimental and Therapeutic Medicine 16(2) (2018)

Lotfollah Davoodi; Babak Masoum; Mahmood Moosazadeh; Hamed Jafarpour; Mohammad Reza Haghshenas; Tahoora Mousavi

9

Mutations in the NS5A gene of hepatitis C virus subtype 1b and response to peg-IFNα-2a/RBV combination therapy in Azerbaijani patients

Archives of Virology 159(11) (2014)

Farah Bokharaei‐Salim; Hossein Keyvani; ‪Mostafa Salehi-Vaziri; Farzin Sadeghi; Seyed Hamidreza Monavari; Leila Mehrnoush; Seyed Moayed Alavian

10

lasma Zinc Level in Hepatitis C Patients With or Without Beta Thalassemia Major; Is There Any Difference?

Hepatitis Monthly 13(8) (2013)

Mohammad Abbasinazari; Bita Behnava; Yunes Panahi; Azita H. Talasaz; Shima Salimi; Maryam Keshvari; Leila Mehrnoush; Prof. Md. Enamul Karim; Mohammad Gholami Fesharaki; Mansour Asgharinia; Seyed Moayed Alavian

11

Adherence to Chronic Hepatitis C Treatment Regimen: First Report From a Referral Center in Iran

Hepatitis Monthly 13(6) (2013)

Saeedeh Ravi; Mohsen Nasiri Toosi; Iman Karimzadeh; Mehdi Ahadi-Barzoki; Hossein Khalili

12

Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C

Hepatitis Monthly 15(9) (2015)

Mahdiyar Pouresmaeeli; Seyed Moayed Alavian; Maryam Keshvari; Shima Salimi; Leila Mehrnoush

13

Efficacy and Safety of Sofosbuvir and Ribavirin for Treating Chronic Hepatitis C, Genotype 3: Experience of a Tertiary Care Hospital at Karachi, Pakistan

Cureus 11(4) (2019)

Nazish Butt; Sehrish Reema; Muhammad Ali Khan; Amanullah Abbasi; Sehrish Butt; Mohammad Masood Khoso; Ali Akbar; Farhan Haleem; Ghulam Basit Mahesar; Anoshia Fahad; Talha Qureshi

14

Vitamin D in Standard HCV Regimen (PEG-Interferon Plus Ribavirin), Its Effect on the Early Virologic Response Rate: A Clinical Trial

Razavi International Journal of Medicine 4(2) (2016)

Hasan Vosoghinia; Abbas Esmaeilzadeh; Azita Ganji; Seyed Mousalreza Hosseini; Saeid Amel Jamehdar; Maryam Salehi; Ali Bahari; Omid Ghanaei; Maryam Sahebari; Farnood Rajabzadeh; Kamran Ghaffarzadehgan; Ladan Goshayeshi

15

Predicting the Outcomes of Combination Therapy in Patients With Chronic Hepatitis C Using Artificial Neural Network

Hepatitis Monthly 14(5) (2014)

Forough Sargolzaee Aval; Nazanin Behnaz; Mohamad Reza Raoufy; Seyed Moayed Alavian

16

Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population

Clinics and Research in Hepatology and Gastroenterology 43(5) (2019)

Amitis Ramezani; Kazem Baesi; Mohammad Banifazl; Minoo Mohraz; Farzin Khorvash; Majid Yaran; Payam Tabarsi; Amir hosein Dalirrooyfard; Fatemeh Motevalli; Anahita Bavand; Arezoo Aghakhani

17

The Evaluation of Interferon Lambda 4 rs368234815 as a Predictor Factor in Treated Patients with Chronic Hepatitis C Genotype 1a Infection

Indian Journal of Medical Microbiology 35(2) (2017)

Shahram Jalilian; Seyed Mahmoud Latifi; Manoochehr Makvandi; Ali Teimoori; Azarakhsh Azaran; Mehdi Parsanahad; Gholam Abbas Kaydani

18

Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013

Hepatitis Monthly 13(11) (2013)

Nasser Ebrahimi Daryani; Seyed Moayed Alavian; Mohammad Hossein Somi; Mohammad Nami

19

Treatment Outcome in Chronic Hepatitis C Infection: A Four Years Survey Among Iranian Patients

Global Journal of Health Science 7(3) (2014)

Ali Akbar Hajiaghamohammadi; Rasoul Samimi; Arash Miroliaee; Amir Mohammad Kazemifar; Masoumeh Nazem

20

The role of hepatic progenitor cells in predicting response to therapy in Egyptian patients with chronic hepatitis C, genotype 4

African Health Sciences 19(1) (2019)

Thanaa Helal; Nehal Ahmed Radwan; Heba Mahmoud; Ahmed Medhat Zaki; Naglaa Samier Ahmed; Ali A Wahib; Ahmed Aref

21

Some Considerations About Cardiac Toxicity of Combination Therapy for Chronic Hepatitis C

Hepatitis Monthly 13(5) (2013)

Reza Karbasi-Afshar; Amin Saburi

22

Hepatitis C Therapy – Related Haematological Side Effects are Associated with Treatment Outcome / Hematološka Neželjena Dejstva Terapije Hepatitisa C Su Povezana Sa Ishodom Lecenja

Serbian Journal of Experimental and Clinical Research 17(1) (2016)

Vuk R. Vukovic; Dejan Baskić; Željko Mijailović; Predrag M. Djurdjevic

24

Risk Factors for Migraine Attacks in Patients Undergoing Treatment for Hepatitis C

Iranian Red Crescent Medical Journal 19(1) (2016)

Razie Salesi; Asieh Salesi; Faraidoon Haghdoost; Seyed Moayed Alavian

25

Hepatitis C virus genotype 3a: Predictive factors associated with treatment response in patients of Peshawar.

The Professional Medical Journal 26(08) (2019)

Amina Gul; Naheed Gul; Ijaz Ali; Jawad Ahmed

26

HCV infection and frequency of distribution.

The Professional Medical Journal 26(10) (2019)

Nighat Aslam; Khalid Nadeem Asif; Sadia Zafar; Amer Jamil